Lexagene Holdings Inc
LSE:0V43
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lexagene Holdings Inc
LSE:0V43
|
US |
|
A
|
Affymax Inc
OTC:AFFY
|
US |
|
Grand Field Group Holdings Ltd
HKEX:115
|
HK |
|
B
|
Baroda Extrusion Ltd
BSE:513502
|
IN |
|
N
|
Nexgen Energy Ltd
NYSE:NXE
|
CA |
|
Healthlynked Corp
OTC:HLYK
|
US |
|
P
|
PA Resources Bhd
KLSE:PA
|
MY |
|
V
|
Volvo AB
XBER:VOL1
|
SE |
|
Guardforce AI Co Ltd
NASDAQ:GFAI
|
TH |
|
Riken Corp
TSE:6462
|
JP |
Lexagene Holdings Inc
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 34 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The firm's MiQLab is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its on-site, automated rapid pathogen detection technology is used for testing in human clinical diagnostics, veterinary diagnostics, food safety, and more. Its veterinary diagnostics system enables veterinarians to rapidly identify infectious pathogens and antibiotic resistance factors in cats and dogs, providing actionable insights in initial diagnosis and prescribed therapies.
Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 34 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing a fully automated, rapid pathogen detection system for use at the point-of-need where samples are collected, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The firm's MiQLab is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its on-site, automated rapid pathogen detection technology is used for testing in human clinical diagnostics, veterinary diagnostics, food safety, and more. Its veterinary diagnostics system enables veterinarians to rapidly identify infectious pathogens and antibiotic resistance factors in cats and dogs, providing actionable insights in initial diagnosis and prescribed therapies.
